Trade JnJ ^JNJ

Jim Cramer on Johnson & Johnson: "It's a Textbook Slowdown Stock"

Protagonist Therapeutics Soars as FDA Approves ICOTYDE for Plaque Psoriasis, Triggers $50M Milestone - Daily Political

Union Bancaire Privee UBP SA Has $33.66 Million Stake in Johnson & Johnson $JNJ - Markets Daily

Monte Rosa J J Supply Deal Refocuses MRT 2359 Prostate Cancer Story

Top Healthcare Stocks To Research - March 21st - Daily Political

Johnson & Johnson $JNJ Stock Holdings Lifted by Park National Corp OH

Park Avenue Securities LLC Acquires 23,337 Shares of Johnson & Johnson $JNJ

GoalVest Advisory LLC Has $1.33 Million Position in Johnson & Johnson $JNJ

10,212 Shares in Johnson & Johnson $JNJ Acquired by Investment Research Partners LLC

Union Bancaire Privee UBP SA Has $33.66 Million Holdings in Johnson & Johnson $JNJ - Stock Observer

GAMMA Investing LLC Buys 7,245 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Bought by AIA Group Ltd

Swiss Life Asset Management Ltd Lowers Stock Position in Johnson & Johnson $JNJ - Daily Political

GoalVest Advisory LLC Acquires 5,194 Shares of Johnson & Johnson $JNJ - Daily Political

Jacobs & Co. CA Sells 2,321 Shares of Johnson & Johnson $JNJ - Daily Political

Best Healthcare Stocks To Research - March 20th - Markets Daily

Promising Medical Stocks To Research - March 20th - Daily Political

Johnson & Johnson Prostate Cancer Trial Adds Depth To Valuation Debate

Johnson & Johnson $JNJ Stock Holdings Increased by Mirabella Financial Services LLP

Allworth Financial LP Raises Stake in Johnson & Johnson $JNJ

Is It Too Late To Consider Johnson & Johnson (JNJ) After A 49.8% One-Year Surge? - Simply Wall St News

Johnson & Johnson (NYSE:JNJ) Price Target Raised to $280.00

RIA Advisory Group LLC Has $325,000 Stock Position in Johnson & Johnson $JNJ - Stock Observer

Barclays Sees Continued Strength in Johnson & Johnson (JNJ) Pharma Business

Mirabella Financial Services LLP Has $2.62 Million Stake in Johnson & Johnson $JNJ - Daily Political

Groupama Asset Managment Sells 2,495 Shares of Johnson & Johnson $JNJ - Daily Political

GI Innovation Announces First Clinical Supply Agreement to Explore Combination Therapy for Prostate Cancer - PR Newswire APAC

Jim Cramer on Johnson & Johnson: "It Should Have Gone Higher, But It Just Shows You How Hard It Is to Buck Stagflation Theories"

Jim Cramer on How to Navigate Wednesday's Tough Tape: 7 Stocks in Focus - Insider Monkey

Barclays Boosts Johnson & Johnson (NYSE:JNJ) Price Target to $234.00

Medical Stocks To Watch Today - March 19th - Stock Observer

Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know

Wilmington Savings Fund Society FSB Sells 102,362 Shares of Johnson & Johnson $JNJ - Markets Daily

Tweedy Browne Co LLC Sells 2,710 Shares of Johnson & Johnson $JNJ - Markets Daily

Portus Wealth Advisors LLC Takes $1.05 Million Position in Johnson & Johnson $JNJ - Markets Daily

Wilmington Savings Fund Society FSB Sells 102,362 Shares of Johnson & Johnson $JNJ - Stock Observer

4,385 Shares in Johnson & Johnson $JNJ Purchased by ARQ Wealth Advisors LLC

Johnson & Johnson $JNJ Shares Purchased by Achmea Investment Management B.V.

2 Reasons to Buy Johnson & Johnson Stock Like There's No Tomorrow - AOL

Portus Wealth Advisors LLC Takes Position in Johnson & Johnson $JNJ - Stock Observer

Does FDA Approval Of Oral Psoriasis Drug ICOTYDE Reshape The Bull Case For Johnson & Johnson (JNJ)? - Simply Wall St News

HSBC Sees Healthcare Strength, Lifts Johnson & Johnson (JNJ) Price Target

ICOTYDE Approval Adds New Growth Angle To Johnson & Johnson Valuation Story

J&J Unit Urges Court to Set Aside $1.6 Billion Fraud Judgment

Top Healthcare Stocks To Follow Today - March 18th - Markets Daily

Icotyde psoriasis pill from J&J to rival Tremfya Skyrizi IL-23 shots

J&J, Protagonist win clearance for Icotyde in plaque psoriasis | BioWorld

US FDA approves J&J's oral psoriasis pill

ICOTYDE is the first and only IL-23R targeted oral peptide t

Johnson & Johnson Says FDA OKs ICOTYDE, First Oral IL-23 Receptor Antagonist For Plaque Psoriasis

Danske Bank A S Makes New $367.47 Million Investment in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ is Livforsakringsbolaget Skandia Omsesidigt's 9th Largest Position

Captrust Financial Advisors Purchases 4,375 Shares of Johnson & Johnson $JNJ

1,981,807 Shares in Johnson & Johnson $JNJ Acquired by Danske Bank A S - Stock Observer

Icotyde's in; wave of switchers to oral psoriasis Protagonist? | BioWorld

Barbarian Taps R/GA Vet Tier To Develop New Integrated Offering 03/18/2026

Assessing Johnson & Johnson (JNJ) Valuation After Recent Share Price Pullback - Simply Wall St News

Oncology Reliance And MedTech Execution Will Threaten Long Term Earnings Stability

Johnson & Johnson (NYSE:JNJ) Sees Significant Growth in Short Interest

Johnson & Johnson (NYSE:JNJ) Stock Price Down 2.1% - Here's What Happened

Healthcare Stocks To Consider - March 17th - Markets Daily

Johnson & Johnson (NYSE:JNJ) Given New $280.00 Price Target at HSBC

Johnson & Johnson (JNJ) Forecast: Extended Rally Signals Patience for Buyers

Why One Analyst Thinks Johnson & Johnson Reaches $280 - AOL

Mariner LLC Buys 50,593 Shares of Johnson & Johnson $JNJ

Mairs & Power Inc. Trims Stake in Johnson & Johnson $JNJ

Mairs & Power Inc. Sells 24,967 Shares of Johnson & Johnson $JNJ

Moors & Cabot Inc. Has $22.60 Million Holdings in Johnson & Johnson $JNJ

Mercer Global Advisors Inc. ADV Buys 64,373 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Bought by Moneta Group Investment Advisors LLC - Markets Daily

Fred Alger Management LLC Acquires 7,871 Shares of Johnson & Johnson $JNJ

Mestag Therapeutics Announces $40 Million Financing and Appoints Chief Medical Officer and Chief Development Officer in Preparation to Enter the Clinic

9,150 Shares in Johnson & Johnson $JNJ Bought by Marshall Investment Management LLC - Daily Political

Does Monte Rosa (GLUE)-J&J ERLEADA Supply Deal Reframe GLUE's MYC Degrader Investment Story? - Simply Wall St News

Mestag $40m raise takes cash haul to date to $95m and fuels new growth

Is It Time To Reassess Johnson & Johnson (JNJ) After Strong Multi Year Share Price Gains

Johnson & Johnson (JNJ) Targets Opportunities around Multiple Myeloma with TECVAYLI

Volatility has boosted dividend stocks. These are one firm's favorites

Healthcare Stocks To Follow Now - March 16th - Markets Daily

Focus Partners Wealth Has $240.15 Million Holdings in Johnson & Johnson $JNJ - Markets Daily

Jain Global LLC Buys New Holdings in Johnson & Johnson $JNJ

Bollard Group LLC Boosts Stake in Johnson & Johnson $JNJ - Markets Daily

Johnson & Johnson $JNJ Shares Sold by Hamlin Capital Management LLC

Johnson & Johnson $JNJ Position Increased by Gotham Asset Management LLC

Johnson & Johnson $JNJ Shares Sold by Fayez Sarofim & Co

EagleClaw Capital Managment LLC Acquires 3,805 Shares of Johnson & Johnson $JNJ - Markets Daily

Focus Partners Wealth Acquires 37,682 Shares of Johnson & Johnson $JNJ - Stock Observer

Johnson & Johnson $JNJ Holdings Raised by Elevation Point Wealth Partners LLC

Capitolis Liquid Global Markets LLC Cuts Stock Holdings in Johnson & Johnson $JNJ - Markets Daily

Capitolis Liquid Global Markets LLC Sells 314,800 Shares of Johnson & Johnson $JNJ

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

Fed Independence on the Line? Political Influence in 2026

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

US Economic Outlook 2026: A Roubini Analysis

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Trading wisdom: how can I improve myself as a trader?

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

EQV stock price today: Is EQV Ventures a good investment?

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

US Economic Signals: Inflation Concerns and Growth Challenges

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

Apple Slashes App Store Commissions in China for Developers

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

India's Silver Demand Surge: New Loan Framework Boosts Market

ADP Employment Data and the Fed's Policy Path: A Closer Look